- Home
- CDXS vs QSI Comparison
CDXS vs QSI Comparison
Compare CDXS & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- QSI
- Stock Information
- Founded
- CDXS 2002
- QSI 2013
- Country
- CDXS United States
- QSI United States
- Employees
- CDXS N/A
- QSI N/A
- Industry
- CDXS Major Chemicals
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- CDXS Industrials
- QSI Health Care
- Exchange
- CDXS Nasdaq
- QSI Nasdaq
- Market Cap
- CDXS 216.6M
- QSI 226.8M
- IPO Year
- CDXS 2010
- QSI N/A
- Fundamental
- Price
- CDXS $2.56
- QSI $1.79
- Analyst Decision
- CDXS Buy
- QSI Strong Buy
- Analyst Count
- CDXS 2
- QSI 3
- Target Price
- CDXS $11.00
- QSI $2.38
- AVG Volume (30 Days)
- CDXS 538.3K
- QSI 13.2M
- Earning Date
- CDXS 10-30-2025
- QSI 11-11-2025
- Dividend Yield
- CDXS N/A
- QSI N/A
- EPS Growth
- CDXS N/A
- QSI N/A
- EPS
- CDXS N/A
- QSI N/A
- Revenue
- CDXS $57,164,000.00
- QSI $3,412,000.00
- Revenue This Year
- CDXS $12.88
- QSI N/A
- Revenue Next Year
- CDXS $21.64
- QSI $219.33
- P/E Ratio
- CDXS N/A
- QSI N/A
- Revenue Growth
- CDXS N/A
- QSI 100.47
- 52 Week Low
- CDXS $1.90
- QSI $0.61
- 52 Week High
- CDXS $6.08
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- CDXS 51.47
- QSI 67.26
- Support Level
- CDXS $2.41
- QSI $1.44
- Resistance Level
- CDXS $2.73
- QSI $1.61
- Average True Range (ATR)
- CDXS 0.12
- QSI 0.17
- MACD
- CDXS 0.03
- QSI 0.04
- Stochastic Oscillator
- CDXS 55.26
- QSI 80.34
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.